SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.65-0.9%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Perry who wrote (2048)5/5/1998 11:11:00 AM
From: Z Analyzer  Read Replies (2) of 9523
 
<<Z Analyzer, your analysis appears to be satisfactory although you make the major
mistake that most analyst do and that is that you are assuming that products now on the
market, drugs soon to be approved and the strong pipeline are not going to dramatically
improve the earnings picture. >>
Actually, if growth and the pipeline were not taken into consideration, a p/e of 30 would never be justified. Historically, such bright prospects for the drug industry leadrs only garnered p/e in the low to mid twenties at best and low teens at worst. And reinvestment of Viagra earnings is no more valuable than reinvestment of any other earnings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext